Population-wide sodium reduction: Reasons to resist

Mayo Clinic Proceedings

Volumn 89, Issue 3, 2014, Pages 426-427

  DiNicolantonio, James J ^a   O'Keefe, James H ^a   Lucan, Sean C ^b  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALDOSTERONE; CHOLESTEROL; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; RENIN; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

CONGESTIVE HEART FAILURE; DIABETES MELLITUS; HUMAN; HYPONATREMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LETTER; SODIUM RESTRICTION; THYROID DISEASE;

CARDIOVASCULAR DISEASES; HUMANS; POTASSIUM, DIETARY; SODIUM, DIETARY;

EID: 84898629918     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.01.007     Document Type: Letter

References (12)

1. Aaron KJ, Sanders PW. Role of dietary salt and potassium intake in cardiovascular health and disease a review of the evidence. Mayo Clin Proc. 2013; 88(9):987-995.
2. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev. 2011;(11):CD004022.
3. Garg R, Williams GH, Hurwitz S, Brown NJ, Hopkins PN, Adler GK. Low-salt diet increases insulin resistance in healthy subjects. Metabolism. 2011;60(7):965-968.
4. Centers for Disease Control and Prevention. 2011 National Diabetes Fact Sheet. http://www.cdc.gov/ diabetes/pubs/estimates11.htm#1). Updated October 25, 2013. Accessed October 17, 2013.
5. Dasgupta PK, Liu Y, Dyke JV. Iodine nutrition: iodine content of iodized salt in the United States [published correction appears in Environ Sci Technol. 2008;42(18):7025]. Environ Sci Technol. 2008; 42(4):1315-1323.
6. Gupta N, Jani KK, Gupta N. Hypertension: salt restriction, sodium homeostasis, and other ions. Indian J Med Sci. 2011;65(3):121-132.
7. Licata G, Di Pasquale P, Parrinello G, et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J. 2003;145(3):459-466.
8. Paterna S, Di Pasquale P, Parrinello G, et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a doubleblind study. J Am Coll Cardiol. 2005;45(12):1997-2003.
9. Paterna S, Fasullo S, Parrinello G, et al. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF study). Am J Med Sci. 2011;342(1):27-37.
10. Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond). 2008;114(3):221-230.
11. McCarron DA, Drüeke TB, Stricker EM. Science trumps politics: urinary sodium data challenge US dietary sodium guideline [editorial]. Am J Clin Nutr. 2010;92(5):1005-1006.
12. O'Donnell MJ, Yusuf S, Mente A, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011;306(20):2229-2238.